chloroquine has been researched along with Chickungunya Fever in 9 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate whether chloroquine (CQ) is more effective than meloxicam for treating early musculoskeletal pain and arthritis following acute chikungunya (CHIK) virus infection." | 9.19 | Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. ( Chopra, A; Saluja, M; Venugopalan, A, 2014) |
| "To evaluate whether chloroquine (CQ) is more effective than meloxicam for treating early musculoskeletal pain and arthritis following acute chikungunya (CHIK) virus infection." | 5.19 | Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. ( Chopra, A; Saluja, M; Venugopalan, A, 2014) |
| "Post-chikungunya joint pain (arthritis or arthralgia) is a clinical concern in endemic regions as it may cause a debilitating illness sometimes years after the acute infection." | 2.82 | Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials. ( Fernando, D; Herath, T; Rajapakse, S; Rodrigo, C; Wickramarachchi, U, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Rashad, AA | 1 |
| Mahalingam, S | 2 |
| Keller, PA | 1 |
| Nothias-Scaglia, LF | 1 |
| Retailleau, P | 1 |
| Paolini, J | 1 |
| Pannecouque, C | 1 |
| Neyts, J | 1 |
| Dumontet, V | 1 |
| Roussi, F | 1 |
| Leyssen, P | 1 |
| Costa, J | 1 |
| Litaudon, M | 1 |
| Rodrigo, C | 1 |
| Herath, T | 1 |
| Wickramarachchi, U | 1 |
| Fernando, D | 1 |
| Rajapakse, S | 1 |
| Cui, X | 1 |
| Sun, J | 1 |
| Minkove, SJ | 1 |
| Li, Y | 1 |
| Cooper, D | 1 |
| Couse, Z | 1 |
| Eichacker, PQ | 1 |
| Torabi-Parizi, P | 1 |
| MartÃ-Carvajal, A | 1 |
| Ramon-Pardo, P | 1 |
| Javelle, E | 1 |
| Simon, F | 1 |
| Aldighieri, S | 1 |
| Horvath, H | 1 |
| Rodriguez-Abreu, J | 1 |
| Reveiz, L | 1 |
| Roques, P | 1 |
| Thiberville, SD | 1 |
| Dupuis-Maguiraga, L | 1 |
| Lum, FM | 1 |
| Labadie, K | 1 |
| Martinon, F | 1 |
| Gras, G | 1 |
| Lebon, P | 1 |
| Ng, LFP | 1 |
| de Lamballerie, X | 1 |
| Le Grand, R | 1 |
| Kumar, M | 1 |
| Topno, RK | 1 |
| Dikhit, MR | 1 |
| Sahoo, GC | 1 |
| Madhukar, M | 1 |
| Pandey, K | 1 |
| Das, P | 1 |
| Chopra, A | 1 |
| Saluja, M | 1 |
| Venugopalan, A | 1 |
| Burt, FJ | 1 |
| Rolph, MS | 1 |
| Rulli, NE | 1 |
| Heise, MT | 1 |
4 reviews available for chloroquine and Chickungunya Fever
| Article | Year |
|---|---|
Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials.
Topics: Anti-Inflammatory Agents; Arthralgia; Chikungunya Fever; Chloroquine; Humans; Hydroxychloroquine; Me | 2022 |
Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
Topics: Alphapapillomavirus; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Chloroquine; COVID-19; | 2021 |
Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.
Topics: Antirheumatic Agents; Chikungunya Fever; Chikungunya virus; Chloroquine; Humans; Hydroxychloroquine; | 2017 |
Chikungunya: a re-emerging virus.
Topics: Aedes; Africa; Alphavirus Infections; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, | 2012 |
1 trial available for chloroquine and Chickungunya Fever
| Article | Year |
|---|---|
Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection.
Topics: Acute Disease; Alphavirus Infections; Arthritis; Chikungunya Fever; Chloroquine; Cytokines; Disease | 2014 |
4 other studies available for chloroquine and Chickungunya Fever
| Article | Year |
|---|---|
Chikungunya virus: emerging targets and new opportunities for medicinal chemistry.
Topics: Alphavirus Infections; Chikungunya Fever; Chikungunya virus; Disease Outbreaks; Europe; Humans; Mode | 2014 |
Jatrophane diterpenes as inhibitors of chikungunya virus replication: structure-activity relationship and discovery of a potent lead.
Topics: Alphavirus Infections; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Diterpenes; Euphorbia | 2014 |
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.
Topics: Animals; Cells, Cultured; Chikungunya Fever; Chikungunya virus; Chloroquine; Cohort Studies; Disease | 2018 |
Molecular docking studies of chloroquine and its derivatives against P23
Topics: Antimalarials; Binding Sites; Chikungunya Fever; Chikungunya virus; Chloroquine; Humans; Molecular D | 2019 |